Cat. No. | Product Name / Activity |
---|---|
2524 | A 205804 |
Selective inhibitor of E-selectin and ICAM-1 expression | |
4228 | A 286982 |
Potent inhibitor of the LFA-1/ICAM-1 interaction | |
6058 | ATN 161 |
α5β1 integrin receptor antagonist | |
3910 | BIO 1211 |
Selective α4β1 (VLA-4) inhibitor | |
5051 | BIO 5192 |
Highly potent and selective inhibitor of integrin α4β1 (VLA-4) | |
4970 | BMS 688521 |
Potent inhibitor of the LFA-1/ICAM interaction | |
6047 | BOP |
Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs | |
6996 | BOP-JF549 |
Yellow fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to Janelia Fluor® 646; fluorogenic; photostable | |
4724 | BTT 3033 |
Selective inhibitor of integrin α2β1 | |
5870 | Cilengitide |
Potent and selective inhibitor of integrins αvβ3 and αvβ5 | |
6785 | E 7820 |
α2 integrin inhibitor; anti-angiogenic | |
3202 | Echistatin, α1 isoform |
αVβ3 and glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor | |
7508 | EMD 527040 hydrochloride |
ανβ6 integrin inhibitor | |
7059 | GLPG 0187 |
Potent αv integrin inhibitor | |
1263 | GR 144053 trihydrochloride |
Glycoprotein IIb/IIIa (integrin αIIbβ3) receptor antagonist. Antithrombotic | |
5114 | K34c |
Potent and selective α5β1 integrin inhibitor | |
4664 | Obtustatin |
Potent and selective α1β1 inhibitor | |
3498 | RGDS peptide |
Integrin binding sequence; inhibits integrin receptor function | |
4527 | TC-I 15 |
Potent α2β1 inhibitor; displays antithrombotic activity in vivo | |
3900 | TCS 2314 |
α4β1 (VLA-4) antagonist |